References
- Bahn, R.S. (2003) "Pathophysiology of Graves' ophthalmopathy: the cycle of disease", J. Clin. Endocrinol. Metab. 88, 1939–1946. Hiromastu, Y. and Bednarczuk, T. (2001) "The role of cytokines in the development of Graves' ophthalmopathy", In: Bahn, R.S., ed, Thyroid Eye Disease (Kluwer Academic Publishers, Boston), pp 45–65.
- Hiromastu, Y. and Bednarczuk, T. (2001) “The role of cytokines in the development of Graves’ ophthalmopathy”, In: Bahn, R.S., ed, Thyroid Eye Disease (Kluwer Academic Publishers, Boston), pp 45–65.
- Pappa, A., Calder, V., Ajjan, R., Fells, P., Ludgate, M., Weetman, AR, et al. (1997) "Analysis of extraocular muscle-infiltrating T cells in thyroid-associated ophthalmopathy (TAO)", Clin. Exp. Immunol. 109, 362–369.
- Hiromatsu, Y, Yang, D., Bednarczuk, T., Miyake, I., Nonaka, K. and Inoue, Y. (2000) "Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmo-pathy", J. ClM. Endocrinol. Metab. 85, 1194–1199.
- Wakelkamp, LM., Bakker, 0., Baldeschi, L., Wiersinga, W.M. and Prummel, M.F. (2003) "TSH-R expression and cytokine profile in orbital tissue of active vs inactive Graves' ophthalmopathy patients", Clin. Endocrinol. (Oxford) 58, 280–287.
- Kumar, S. and Bahn, R.S. (2003) "Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with Graves' ophthalmopathy", J. ClM. Endocrinol. Metal,. 88, 4246–4250.
- Molnar, I. and Balazs, C. (1997) "High circulating IL-6 level in Graves' ophthalmopathy", Autoimmunity. 25, 91–96.
- Salvi, M., Pedrazzoni, M., Girasole, G., Giuliani, N., Minelli, R., Wall, JR., et al. (2000) "Serum concentrations of proinflammatory cytokines in Graves' disease: effect of treatment, thyroid function, ophthalmopathy and cigarette smoking", Eur. J. Endocrinol. 143, 197–202.
- Wakelkamp, LM., Gerding, M.N., Van Der Meer, LW., Prununel, M.F. and Wiersinga, W.M. (2000) "Both Th 1 - and Th2-derived cytokines in serum are elevated in Graves' ophthalmopathy", Clin. Exp. Immunol. 121, 453–457.
- Jyonouchi, S.C., Valyasevi, R.W., Harteneck, D.A., Dutton, CM. and Bahn, R.S. (2001) "Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy", Thyroid 11,929–934.
- Fishman, D., Faulds, G., Jeffery, R., Mohamed-Ali, V., Yudkin, J.S., Humphries, S., et al. (1998) "The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis", J. Clin. Investig. 102, 1369–1376.
- Fernandez-Real, J.M., Broch, M., Vendrell, J., Richart, C. and Rican, W. (2000) "Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects", J. Clin. Endocrinol. Metal,. 85, 1334–1339.
- Humphries, SE., Luong, L.A., Ogg, MS., Hawe, E. and Miller, G.J. (2001) "The interleukin-6-174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men", Eur. Heart J. 22, 2243–2252.
- Villuendas, G., San Millan, J.L., Sancho, J. and Escobar-Morreale, H.F. (2002) "The -597 G A and -174 G C polymorphisms in the promoter of the IL-6 gene are associated with hyperandrogenism", J. Clin. Endocrinol. Metal,. 87, 1134–1141.
- Ferrari, S.L., Ahn-Luong, L., Garner°, P., Humphries, S.E. and Greenspan, S.L. (2003) "Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women", J. Clin. Endocrinol. Metal,. 88,255–259.
- Kubaszek, A., Pihlajamald, J., Komarovski, V., Lindi, V., Lindstrom, J., Eriksson, J., et al. (2003) "Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study", Diabetes 52, 1872 —1876.
- Bednarczuk, T., Hiromatsu, Y, Fukutani, T., Jazdzewski, K., Miskiewicz, R, Osikowska, M., et al. (2003) "Association of cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) gene polymorphism and non-genetic factors with Graves' ophthalmopathy in European and Japanese populations", Eur J. Endocrinol. 148, 13–18.
- Werner, S.C. (1977) "Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association", J. Clin. Endocrinol. Metab. 44, 203–204.
- Woolf, B. (1955) "On estimating the relationship between blood group and disease", Ann. Hum. Genet. 19, 251–253.
- Farid, N.R. and Balazs, C. (1998) "The genetics of thyroid associated ophthalmopathy", Thyroid 8, 407–409.
- Vaidya, B., Kendall-Taylor, P. and Pearce, S.H. (2002) "The genetics of autoinunune thyroid disease", J. ClM. Endocrinol. Metal,. 87, 5385–5397.
- Rivera-Chavez, F.A., Peters-Hybki, DL., Barber, R.C. and O'Keefe, G.E. (2003) "Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses", Shock 20, 218–223.
- Brull, D.J., Montgomery, HE., Sanders, J., Dhamrait, S., Luong, L., Rumley, A., et al. (2001) "Interleukin-6 gene -174g > c and -572g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery", Arterioscler. Thromb. Vasc. Biol. 21, 1458–1463.
- Vozarova, B., Fernandez-Real, J.M., Knowler, W.C., Gallart, L., Hanson, R.L., Gruber, J.D., et al. (2003) "The interleukin-6 (-174) G/C promoter polymorphism is associated with type-2 diabetes mellitus in Native Americans and Caucasians", Hum. Genet. 112, 409–413.
- Pola, R., Flex, A., Gaetani, E., Flore, R., Serricchio, M. and Pola, P. (2003) "Synergistic effect of -174 G/C polymorphism of the interleukin-6 gene promoter and 469 E/K polymorphism of the intercellular adhesion molecule-1 gene in Italian patients with history of ischemic stroke", Stroke 34, 881–885.
- Jahromi, MM., Millward, B.A. and Demaine, AG. (2000) "A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus", J. Interferon Cytokine Res. 20, 885–888.
- Pascual, M., Nieto, A., Mataran, L., Balsa, A., Pascual-Salcedo, D. and Martin, J. (2000) "IL-6 promoter polymorphisms in rheumatoid arthritis", Genes Immun. 1, 338–340.
- Hulkkonen, J., Pertovaara, M., Antonen, J., Pasternack, A. and Hurme, M. (2001) "Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease", Rheumatology (Oxford) 40, 656–661.
- Olomolaiye, 0., Wood, NAP. and Bidwell, J.L. (1998) "A novel Nla III polymorphism in the human IL-6 promoter", Eur. J. Immunogenet. 25, 267.
- Jordanides, N., Eskdale, J., Stuart, R. and Gallagher, G. (2000) "Allele associations reveal four prominent haplotypes at the human interleukin-6 (IL-6) locus", Genes Immun. 1, 451–455.
- Hunt, P.J., Marshall, SE., Weetman, A.P., Bell, J.I., Wass, J.A.H. and Welsh, K.I. (2000) "Cytokine gene polymorphisms in autoimmune thyroid disease", J. ClM. Endocrinol. Metal,. 85, 1984–1988.
- Terry, CE, Loukaci, V. and Green, RR. (2000) "Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation", J. Biol. Chem. 275, 18138–18144.